Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediso’s AnyScan and nanoScan platforms deliver advanced nuclear medicine and hybrid imaging modalities (including triple-modality SPECT/CT/PET), with installations in over 100 countries and collaborations with major clinical, academic and national laboratories for improving imaging in diagnostics and research[1][2][3][4][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediso.